Prevalence of irritable bowel syndrome in patients with fibromyalgia;Prevalência da síndrome do cólon irritável em pacientes com fibromialgia

Revista Brasileira de Reumatologia

Volumn 46, Issue 1, 2006, Pages 16-23

  Helfenstein Jr , Milton ^a,b   Heymann, Roberto ^a   Feldman, Daniel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Fibromyalgia syndrome; Irritable bowel syndrome; Musculoskeletal pain

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; SCORING SYSTEM;

EID: 34748879920     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wolfe F, Smythe HA, Yunus MB et al: The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia: report of the multicentre criteria committee. Arthritis Rheum 33: 160-172,1990.
2. Wolfe F and The Vancouver Fibromyalgia Consensus Group: The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol 23: 534-539, 1996.
3. Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19: 846-849, 1992.
4. Russell IJ. Neurohormonal aspects of fibromyalgia syndrome - Rheum Dis Clin N Am 15: 149-168, 1989.
5. Russell IJ, Vaeroy HJ, Javors M et al: Cerebrospinal fluid biogenic amines in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35: 550-556, 1992.
6. Yunus MB, Dailey JW, Aldag JC et al: Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19: 90-94, 1992.
7. American Gastroenterological Association: American Gastroenterological Association position statement: irritable bowel syndrome. Gastroenterology 112: 2118-2119, 1997.
8. Talley NJ, Spiller R: Irritable bowel syndrome: a little understood organic bowel. Lancet 360: 555-564, 2002.
9. Bradley LA, McKendree-Smith NL, Alberts KR et al: Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheumatol Rep 2: 141-148, 2000.
10. Naliboff BD, Derbyshire SW, Munakata J et al: Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 63: 365-375, 2001.
11. Mitchell CM, Drossman DA: Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 92: 1282-1284, 1987.
12. Saito YA; Schoenfeld P; Locke GR III: The epidemiology of irritable bowel syndrome in North America: A systematic review. Am J Gastroenterol 97: 1910-1915, 2002.
13. Talley NJ, Zinsmeister AR, Melton LJ: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and healthcare utilization. Am J Epidemiol 142: 76-83, 1995.
14. Thompson WG, Longstreth GF, Drossman DA et al: Functional bowel disorders and functional abdominal pain. Gut 45: 1143-1147,1999.
15. Drossman DA, Corazziari E, Talley NJ et al (eds): Rome II Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates, 2000.
16. Talley NJ: Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord 5:1-9, 2005.
17. Corazziari E: Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 18: 613-631, 2004.
18. Corazziari E, Badiali D: How many chronic functional constipations? http://www.anemgi.org/htlm/introduction/html. Último acesso em 17 de março de 2005.
19. Pare P, Ferrazzi S, Thompson WG et al: An epidemiological survey of constipation in Canada: definitions, rates demographics, rvey and predictors of health care seeking. Am J Gastroenterol 96: 3130-3137, 2001.
20. Stewart WF, Liberman FJN, Sandler RS et al: Epidemiology of constipation (epoc) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 94: 3530-3540,1999.
21. Veale D, Kavanagh G, Fielding JF, Fitzgerald O: Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Brit J Rheumatol 30: 220-222,1991.
22. Sperber AD, Atzmon Y, Neumann L et al: Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 94: 3541-3546,1999.
23. Yunus MB, Inanici F, Aldag JC, Mangold RF: Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 27: 485-490, 2000.
24. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18: 728-733, 1991.
25. Bennett RM, Burckhardt CS, Clark SR: Fibrositis impact questionnaire (FIQ) users guide. Division of Arthritis & Rheumatic Diseases. Oregon Health Sciences University. Portland, Oregon, 1991.
26. Spielberger CD, Gorsuch RL, Lushene RE: Manual for the state - trait anxiety inventory. California: Consulting Psychologist Press, 1970.
27. Biaggio AMB, Natalicio L: Inventário de ansiedade traço-estado (IDATE). Rio de Janeiro: Centro Editor de Psicologia Aplicada (CEPA), 1971.
28. Beck AT, Ward CH, Mendelson M et al: An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63,1961.
29. Beck AT, Rush AJ, Shaw BF e cols: Terapia cognitiva da depressão (traduzido por Vera Ribeiro). Zahar, Rio de Janeiro, 1982.
30. Gorenstein C, Andrade L, Pompeia S: Scores of Brazilian university students on the beck depression and the state-trait anxiety inventories. Psychological Reports 77: 635-641,1995.
31. Gorenstein C, Andrade L: Validation of a Portuguese version of the Beck depression inventory and the state-trait anxiety inventory in Brazilian subjects. Braz J Med Biol Res 29: 453-457, 1996.
32. Cott A, Parkinson W, Bell MJ et al: Interrater reliability of the tender point criterion for fibromyalgia. J Rheumatol 19: 1955-1959, 1992.
33. Tunks E, Mc Cain GA, Hart LE et al: The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 22: 944-952, 1995.
34. Jacobs JW, Geenen K, Van der Heide A et al: Are tender points scores assessed by manual palpation in fibromyalgia reliable? An algia investigation into the variance of tender point scores. Scand J Rheumatol 24: 243-247, 1995.
35. Goldenberg DL: Fibromyalgia syndrome: an emerging but controversial condition. JAMA 257: 2782-2787, 1987.
36. Romano TJ: Coexistence of irritable bowel syndrome and fibromyalgia. West Virg Med J 84: 16-18, 1988.
37. Yunus MB, Masi AT, Aldag JC: A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol 16: 62-71, 1989.
38. Triadafilopoulos G, Simms RW, Goldenberg DL: Bowel dysfunction in fibromyalgia syndrome. Digest Dis Sci 36: 59-64,1991.
39. Nishikai M: Fibromyalgia in Japanese. J Rheumatol 19: 110-114, 1992.
40. Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 112: 64-72, 1997.
41. Mertz H, Morgan V, Tanner G et al: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118: 842-848, 2000.
42. Rainville P, Duncan GH, Price DD, Carreir B, Bushnell MC: Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997 277: 968-971, 1997.
43. Mountz JM, Bradley LA, Modell JG et al: Fibromyalgia in women. Arthritis Rheum 38: 926-938, 1995.